Northern Trust
ANAC

Northern Trust’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Northern Trust’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-494,781
Closed -$27.4M – 4386
2016
Q1 		$27.4M Buy
494,781
+409
+0.1% +$30.2K 0.01% 1236
2015
Q4 		$55.8M Buy
494,372
+16,597
+3% +$1.83M 0.02% 735
2015
Q3 		$56.2M Buy
477,775
+75,693
+19% +$9.89M 0.02% 729
2015
Q2 		$31.1M Sell
402,082
-9,431
-2% -$618K 0.01% 1223
2015
Q1 		$23.8M Sell
411,513
-5,312
-1% -$226K 0.01% 1435
2014
Q4 		$13.4M Buy
416,825
+69
+0% +$2.07K ﹤0.01% 1848
2014
Q3 		$10.2M Buy
416,756
+82,211
+25% +$1.67M ﹤0.01% 2027
2014
Q2 		$5.93M Sell
334,545
-12,037
-3% -$194K ﹤0.01% 2401
2014
Q1 		$6.94M Sell
346,582
-30,409
-8% -$590K ﹤0.01% 2347
2013
Q4 		$6.33M Buy
376,991
+19,632
+5% +$272K ﹤0.01% 2396
2013
Q3 		$3.79M Buy
357,359
+84,277
+31% +$737K ﹤0.01% 2689
2013
Q2 		$1.53M Buy
+273,082
New +$1.65M ﹤0.01% 3126

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Northern Trust's ANAC Position: Q2 2016 in Review

Northern Trust sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 494,781 shares — an estimated $27.4M sold.

Northern Trust first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $56.2M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Northern Trust reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Northern Trust sold 494,781 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $27.4M.
  • Northern Trust first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • Northern Trust's ANACOR PHARMACEUTICALS INC COM position peaked at $56.2M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Northern Trust's 13F filing for Q2 2016, filed 12 Aug 2016.